CTD // Fund

DNV Capital

Venture capital firm focused on healthcare and tech companies

DNV Capital

china

DNV Capital is an institutional investor (Conventional VCs) founded in 2011 and headquartered in Shenzhen, China. DiNovA Capital is a seed & early stage focused venture capital firm. Makes investments in territories such as the US and China. Invests in life sciences sectors such as Medical Devices and HealthTech. Notable investments include Sonendo, Venus MedTech, Vessix Vascular. Notable portfolio companies: Sonendo, Venus MedTech, Vessix Vascular.

Stage: Seed, Early Stage, Seed, Early Stage
HQ: Shenzhen, china
Founded: 2011
Website: https://dnvcapital.com/f
LinkedIn: https://linkedin.com/company/dnvcapital

Institutional InvestorHealthcareHealthTechBiotechBiopharmaEdTech

Related startups

Ability

Developer of modulating biotherapeutics to address cancer and autoimmune diseases.

HealthTech · Montreal, Canada

Frontera Health

Provider of AI-powered software automating ABA clinical report writing. The software assists clinicians in creating assessment and diagnostic reports,…

HealthTech · Denver, United States

Aevice Health

Aevice Health develops non-invasive wearable medical devices for continuous remote respiratory monitoring, enabling clinicians to gain insights into…

HealthTech · Singapore, Singapore

📊 Valuation calculator for deal screening — free tool using revenue multiples by sector and round.

⚠️ What makes founders get rejected →

Preparing to pitch DNV Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →